David DeLucia - 09 Jan 2025 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
Chief Financial Officer
Signature
/s/ Michael Hom, Attorney-in-Fact
Issuer symbol
FGEN
Transactions as of
09 Jan 2025
Transactions value $
$0
Form type
4
Filing time
10 Jan 2025, 18:16:27 UTC
Previous filing
18 Dec 2024
Next filing
07 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FGEN Stock Option (Right to Buy) Award $0 +525K $0.00 525K 09 Jan 2025 Common Stock 525K $0.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in equal amount quarterly over 4 years measured from 1/9/2025.